Taysha Gene Therapies
TSHA
#7675
Rank
โ‚ฌ0.25 B
Marketcap
1,26ย โ‚ฌ
Share price
-29.53%
Change (1 day)
-52.19%
Change (1 year)

Taysha Gene Therapies (TSHA) - Cash on Hand

Cash on Hand as of December 2024 : โ‚ฌ0.12 Billion

According to Taysha Gene Therapies's latest financial reports the company has โ‚ฌ0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Taysha Gene Therapies - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ0.13 B2.61%
2023-12-31โ‚ฌ0.13 B58.93%
2022-12-31โ‚ฌ81.92 M-37.77%
2021-12-31โ‚ฌ0.13 B-35.55%
2020-12-31โ‚ฌ0.20 B
2019-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ0.23 B 84.10%๐Ÿ‡บ๐Ÿ‡ธ USA